New Platform that can Test Thousands of COVID-19 Samples may cause Revolutionary Changes in the Robotics Industry
Posted On April 09, 2021
One of the crucial activities that need to be undertaken to fight the ongoing pandemic is to identify positive samples accurately and instantly. However, this feat is now even harder to achieve with new forms of variants being discovered by scientists.
In order to solve this problem, researchers recently tapped into robotic technology so that a feasible solution could be developed for testing the virus in the patients. Hence, they have managed to design a platform that has the ability to screen thousands of COVID-19 samples at once. It might even cause a complete revolution in the method of lab testing of viruses and other types of pathogens. This is a ground-shattering development in the Robotics Market because this newly made platform is automated and scalable. In addition, it has the capacity to analyze thousands of samples in a single instrument run, which is not a little hurdle in itself.
The team developed this platform with the help of fingerprint sequencing. To achieve the possibility of sampling variants, they did quick sequencing of fingerprint regions of the viral genome and looked at key mutations. As a consequence, a great platform was developed that also has the added benefit of being cost-effective with other advantages. The study reports that the platform only gives out a cost of about 8$ USD per test while running several samples at once. This is because the cost per sample decreases due to the economics of scale.
The platform as envisaged is extremely reliable and also has a great rate of adaptability. The turnaround for the same is approximately 24 hours. Furthermore, it is also easy to operate as most of the functions are autonomous.
SPAR –Seq System, as the platform, is referred to be a cutting edge technology with the quality of bringing good changes in the sampling technology sectors. It is not to forget that technologies like these are of utmost importance in the current time, where the pandemic does not look to be ending anytime sooner. Also, this advancement will also benefit the scientists by providing them a better understanding of the epidemiology and spread of novel mutants around the province.